HMGB1 and atopic eczema: HMGB1 has emerged as a promising biomarker in autoimmune and autoinflammatory skin diseases, as accumulating evidence links its disease-specific expression patterns to inflammatory cascades in conditions such as vitiligo, psoriasis, atopic dermatitis, and pemphigus.